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Abstract
Background
To investigate aortic dimensions in women with Turner syndrome (TS) in relation to aortic valve morphology,
blood pressure, karyotype, and clinical characteristics.
Methods and results: A cross sectional study of 102 women with TS (mean age 37.7; 18-62 years) examined by
cardiovascular magnetic resonance (CMR- successful in 95), echocardiography, and 24-hour ambulatory blood
pressure. Aortic diameters were measured by CMR at 8 positions along the thoracic aorta. Twenty-four healthy
females were recruited as controls. In TS, aortic dilatation was present at one or more positions in 22 (23%). Aortic
diameter in women with TS and bicuspid aortic valve was significantly larger than in TS with tricuspid valves in
both the ascending (32.4 ± 6.7 vs. 26.0 ± 4.4 mm; p < 0.001) and descending (21.4 ± 3.5 vs. 18.8 ± 2.4 mm;
p < 0.001) aorta. Aortic diameter correlated to age (R = 0.2 - 0.5; p < 0.01), blood pressure (R = 0.4; p < 0.05), a
history of coarctation (R = 0.3; p = 0.01) and bicuspid aortic valve (R = 0.2-0.5; p < 0.05). Body surface area only
correlated with descending aortic diameter (R = 0.23; p = 0.024).
Conclusions
Aortic dilatation was present in 23% of adult TS women, where aortic valve morphology, age and blood pressure
were major determinants of the aortic diameter.
Background
Women with Turner syndrome (TS) face a significant
risk of premature cardiovascular death due to aortic dis-
section, ischemic heart disease and stroke [1]. The high
prevalence of congenital cardiovascular malformations
[2,3] and hypertension also contributes adversely to the
increased cardiovascular morbidity and mortality [4].
Careful and continuous monitoring of the aorta in this
patient group is therefore of vital importance [5] and
cardiovascular magnetic resonance (CMR) may provide
superior imaging compared with echocardiography [6].
Aortic dilation has been found in 12-32% [6-9] of rela-
tively young women with TS. Since the final height of
women with TS is reduced, it may well be needed to
correct for this potential confounder when analysing
aortic measurements and adjusting for body surface area
(BSA) has been performed on data from women with
TS [8]. Indexing to segments of the aorta that are unaf-
fected by disease and reflect normal aortic size for the
individual has also been used (“aortic diameter index”)
[8,9]. Recent echocardiographic studies in women with
TS have strongly indicated that dilation of the aortic
root particularly occurs in those with bicuspid aortic
valve (BAV) [10,11]. However, the combined impact of
BAV, and other risk factors such as blood pressure,
repaired coarctation, body composition and dysmetabo-
lism on the thoracic aorta in women with TS has to our
knowledge not been examined.
We therefore studied to what extent aortic dilatation,
the presumed forerunner of dissection, in TS is influ-
enced by such risk factors. Accordingly, the aims of the
present study performed in a group of women with TS
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any medium, provided the original work is properly cited.were to investigate aortic dimension in relation to aortic
valve morphology, BSA and other measures of anthro-
pometry, blood pressure and clinical characteristics typi-
cal for TS and to establish normative data on aortic
diameter in TS.
Methods
One hundred and two women (aged 38 ± 11 years,
range: 18-62 years) with TS verified by karyotyping (45,
X: n = 58 (57%); other karyotypes (mosaics, isochromo-
somes): n = 44 (43%)) were included consecutively
through the National Society of Turner Contact Groups
in Denmark and the local Out-patient clinic. Patients
with malignant disease, clinically significant liver disease
and mechanical heart valves were excluded. Twenty-four
healthy women (aged 43 ± 10 years, range: 25-63) taking
no daily medication (oral contraceptives accepted),
recruited through advertising, served as controls. The
protocol was approved by the Aarhus County Ethical
Scientific Committee (# 20010248) and complies with
the Declaration of Helsinki. Informed consent was
obtained from all participants.
All trial participants were admitted to the research
laboratory at 8 am after an overnight fast (10 h). Body
weight was measured to the nearest 0.1 kilogram (kg) and
body height was measured to the nearest 0.5 cm. The pre-
sence of webbed neck and/or low hairline was noted. Pre-
viously diagnosed hypertension was registered.
Information on the age at menarche, age when exogenous
estrogen was introduced, age at premature menopause,
and duration of hormone replacement therapy (HRT)
were registered, enabling summation of total estrogen
exposure (in years). The duration of estrogen insufficiency
were estimated as the number of years between the age of
13 years and 53 years, during which participants neither
were taking HRT, nor had spontaneous menstrual bleed-
ings. Due to claustrophobia (n = 5), cochlear implant
(n = 1) and technical problems (n = 1) CMR was per-
formed on 95 of 102 participants. Echocardiography was
performed in 101 of 102. Echocardiography and CMR
were completed for all control women.
Cardiovascular Magnetic Resonance
All examinations were performed on a 1.5 Tesla whole
body MR scanner (ACS-NT, Philips Medical Systems;
maximum gradient performance 30 mT/m amplitude,
slew rate 150 T/m/s) using a commercially available
5-element cardiac coil. After initial scouts a 3D block of
data (27 cm (AP) × 15 cm (FH) × 36 cm (LR)) covering
the ascending aorta, aortic arch and descending thoracic
aorta was acquired. A nearly isotropic 3D steady-state
free precession (SSFP) navigator and ECG triggered
sequence acquired in diastole during free breathing was
used [12]. The voxel size was 1.4 mm × 1.4 mm × 1.5
mm. Since only extra-cardiac vessels were studied the
length of the diastolic acquisition window was increased
to approximately 250 ms. This allowed the total scan
time of 8-12 min, depending on the heart rate and
breathing pattern. In the attempt to minimize effective
time in the scanner to the trial subject, the acquisition
window was set at 230 ms. This resulted in capturing of
end-diastole in some patients, with a resulting inferior
image quality in a fraction of the patient at the most
dynamic portion of the aorta (sinus and hinge level). As
a result, we refrained from measurement of these
positions.
All aortic measurements were obtained with dedicated
prototype software (Systematic Software Engineering,
Aarhus, Denmark) that allowed real time reconstruction
of any plane in the 3D stack of data. Any chosen plane
was then interactively positioned across the aorta at the
following 8 positions (pos): Sinotubular junction (pos1);
ascending aorta midway between the sinotubular junc-
tion and the innominate artery (pos2); ascending aorta
immediately proximal to innominate artery (pos3); prox-
imal transverse arch midway between innominate and
left carotid artery (pos4); distal transverse arch just
proximal to left subclavian artery (pos5); aortic isthmus
immediately distal to the left subclavian artery (pos6);
descending aorta between left pulmonary artery and top
of left atrium (pos7) and descending aorta at the most
caudal border of the left atrium (pos8) (Figure 1A).
To visualize anatomical landmarks and secure correct
angulation relative to the aortic wall, especially in the
aortic arch, two imaging planes orthogonal to each
o t h e ra sw e l la st h ep l a n eo fm e a s u r e m e n tw e r ed i s -
played simultaneously while defining the plane of mea-
surement during the naviga t i o ni nt h e3 Dd a t ab l o c k
(Figure 1B). For locations defined by the branching of
an artery, the position was defined as the plane rectan-
gular to the aorta as close to the branching artery as
possible without any sign of branching visible. The lar-
gest diameter was measured manually at each plane of
measurement. The largest diameter was used in subse-
quent comparisons [12].
Cut-off levels for dilation and aneurysm were calcu-
lated from the CMR diameters in the control popula-
tion. Dilation was defined as a diameter exceeding the
mean + 2SD with aneurysm defined as a diameter larger
than 1.5 times the mean. The ratio of the ascending and
descending aortic dimensions relative to position 8 was
calculated and a ratio greater than 1.5 defined as aortic
dilation. Both methods of defining aortic dilation were
used in the data evaluation.
Echocardiography
Echocardiographic examinations were performed by the
same observer on a GE Vivid Five (GE Medical System,
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Page 2 of 10Horten, Norway) with a 2.5 MHz transducer and using
second harmonic modalities [13]. Aortic diameters
were measured at pos1, pos3 and pos6 (Figure 1A) and
dilation at the sinotubular junction (pos 1) defined as a
diameter above 32 mm [14]. Finally, aortic valve mor-
phology was determined and characterized as tricuspid
(TAV), BAV or undetermined.
Ambulatory blood pressure
Twenty-four hour ambulatory blood pressure (AMBP)
was recorded with a Spacelabs 90207 (Redmond,
Washington, USA), using oscillometric technique. Blood
pressures were measured from the left upper arm, using
an individualised cuff size, and readings were obtained
every 20 minutes, with day- and night-time defined
from diary-registered bed and rise-time. Hypertension
was defined as a mean day time AMBP > 130/85 mmHg
and/or night-time values >1 1 0 / 7 0m m H g ,w h i c hi na n
outcome driven study corresponds to the cardiovascular
risk of a clinic blood pressure greater than 130/85
mmHg [15]. Hypertension was defined independently of
antihypertensive treatment.
Statistical methods
Statistical calculations were done using SPSS 15.0. Nor-
mality of data, including Levene’s test for equality of
variances, was tested with the Shapiro-Wilk test of nor-
mal distribution. Correlation analysis between aortic
dimensions and normally distributed parameters was
performed with Pearson’s coefficient of correlation,
while Spearman’s rank correlation analysis was used to
examine the relation between non-normally distributed
data. The c
2 test was used to test difference between
groups, using the Fisher’s exact test if group number
were < 5. Multiple backward stepwise linear regression
models were constructed to examine the principal deter-
minants of aortic dimensions, where independent vari-
ables were omitted from the model when p > 0.1.
P-values less than 5% were considered significant.
Aortic diameters adjusted for BSA or height as sug-
gested by Ostberg et al [8], did not influence the results
significantly. Diameters adjusted for BSA are reported.
Results
Characteristics of participants are listed in table 1. The
control subjects were taller, heavier, and had higher
BSA, but similar BMI. Fasting glucose, HbA1C, and
lipids were comparable between groups (Table 1). In the
TS group 57 (58%) were of 45,X karyotype and 43 (44%)
were of other karyotypes. Among the women with TS
the median duration of HRT was 19 years (ranging from
none to 36 years), and the median time of HRT defi-
ciency was 3 years (ranging from none to 40). Twelve of
81 patients in the age-group 18-53 had chosen never to
receive HRT, seven of these had spontaneous
menstruation.
Aortic valve morphology
BAV was found in 26 of 102 (25%) women with TS, and
a tricuspid aortic valve was seen in 73 women. Aortic
valve morphology could not be accurately defined in 3
(3%). None of the controls had tricuspid aortic valves.
Blood pressure and aortic coarctation
Hypertension was present in 55/96 (58%) of women
with TS and in 9/24 (38%) of the controls. In women
Figure 1 CMR measuring positions, where pos1, pos3 and pos 6 were also measured by echocardiography. Post-processing of 3D
isotropic CMR in positon 1 of the ascending aorta, at sinotubular level. It illustrates the ability to ensure precise and reproducible measurement
of aortic diameter, where accuracy is ensured by the use of 3 separate planes placed perpendicular to each other and the aortic wall at the
position of measuremtn.
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those with a tricuspid valve and in 15/26 (58%) with
BAV. Repaired aortic coarctation was more frequent in
TS women with BAV (5/24, 21%) than it was with a tri-
cuspid aortic valve (3/65, 5%).
Aortic diameters
The absolute aortic diameters obtained by CMR in the
TS population was not different in the ascending aorta
compared to the control group (Table 2). However, a
wider range and greater standard deviation was seen in
TS. At the distal transverse aortic arch (pos5) and aortic
isthmus (pos6) the diameter was smaller in TS (Table 2).
Women with TS and BAV had significantly larger dia-
meters at all positions except from pos5 and pos6, when
compared to those with a tricuspid valve (Table 3). A
subgroup analysis of aortic diameter in women with TS
and no coarctation (n = 79) revealed a significantly lar-
ger diameter of the ascending aorta (pos1, pos2 and
pos4) but not the descending aorta (pos7, pos8) in the
BAV subgroup compared with the TAV subgroup.
Aortic ratio
The aortic ratio was comparable in TS and controls,
with the exception of a smaller ratio in TS at pos5 and
pos6 (p= < 0.001) (Figure 2). At pos2 the mean ratio in
TS was considered abnormal (1.52 ± 0.26), even though
the ratio at this position was not significantly different
from the ratio in the control population (p = 0.4). Ratios
greater than >1.5 were found at one or more positions
in 46/95 (48%) of TS women (pos1 (32%); pos2 (43%);
pos3 (21%); pos4 (12%)). Nine out of 24 (37.5%) controls
had an enlarged ratio at one or more positions.
Aortic dilation
On CMR, aortic dilation was found at one (or more) of
8 positions in 22 (23%) women with TS; amongst these,
thirteen were dilated at two or more sites and 11 (85%)
had BAV. Aortic diameter and enlargement at pos2 is
depicted in figure 3. Three women with TS and BAV
fulfilled the criteria for aortic aneurysm (Table 4), where
dilation was present in 6/8 positions in one patient and
in 4/8 positions in the other two women. Two control
Table 1 Clinical characteristics of participants.
TS Controls
N Mean ± SD Range n Mean ± SD Range p-value
Age (years) 102 37.7 ± 10.9 18 - 62 24 42.7 ± 10.4 25 - 63 0.04
Height (cm) 102 147.3 ± 7.1 134 - 171 24 168.2 ± 5.9 155 - 177 < 0.001
Weight (kg) 101 57.6 ± 12.4 34 - 104 24 69.4 ± 7.3 57 - 84 < 0.001
BMI (kg/m
2) 101 26.6 ± 5.6 16 - 48 24 24.6 ± 3.2 21 - 34 0.1
BSA (m
2) 101 1.49 ± 0.16 1.2 - 2 24 1.79 ± 0.092 1.6 - 2 < 0.001
24 h AMBP (mm Hg) Systolic 97 122 ± 14 99 - 192 24 115 ± 9 100 - 133 0.03
Diastolic 97 77 ± 11 54 - 134 24 73 ± 7 63 - 87 0.1
Estrogen deficiency (yrs) 94 6.4 ± 8.3 0 - 40
GH treatment (years) 23 5.5 1 - 12
Antihypertensive treatmeant (years) 24 5.3 0.5 - 19
Baseline data in TS and healthy female control subjects.
AMBP are average values of 24-hour ambulatory blood pressure registration (day and night time values not shown).
Table 2 Aortic dimensions obtained with CMR in TS and controls. TS dimensions adjusted for BSA are shown.
CMR TS CMR controls TS vs C CMR TSkorrBSA TSkorrBSA vs C
n Mean ± SD
(range)(mm)
n Mean ± SD
(range)(mm)
P-value Mean ± SD
(range)(mm)
P-value
Sinotubular junction 95 25.4 ± 4.7 (17-39) 24 26.4 ± 2.3 (22-32) 0.4 26.2 ± 4.6 0.8 0.8
Ascending aorta 95 27.4 ± 5.7 (16-48) 24 27.6 ± 2.7 (22-32) 0.9 28.2 ± 5.7 0.6 0.6
Aorta proximal to innominate artery 95 25.4 ± 4.0 (18-38) 24 26.3 ± 2.4 (22-31) 0.3 26.3 ± 4.0 1.0 1.0
Prox. transverse aortic arch 73 23.5 ± 3.7 (17-34) 20 24.9 ± 2.2 (21-30) 0.1 24.5 ± 3.7 0.6 0.6
Distal transverse aortic arch 94 20.5 ± 2.6 (14-29) 22 23.5 ± 1.9 (20-27) < 0.001 21.6 ± 2.6 0.001 0.001
Aortic isthmus 94 19.3 ± 2.4 (14-28) 23 22.2 ± 2.0 (18-26) < 0.001 20.2 ± 2.4 < 0.001 < 0.001
Descending aorta 95 19.4 ± 2.9 (14-31) 24 20.2 ± 1.8 (17-26) 0.2 21.1 ± 2.8 0.1 0.1
Descending aorta (diaphragm level) 94 18.2 ± 2.4 (13-27) 24 18.9 ± 1.9 (16-24) 0.2 20.1 ± 2.4 0.02 0.02
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more regions.
On echocardiography, dilation at the aortic sinus was
found in 8 TS women (Table 4) and in two controls. All
8 patients also fulfilled the criteria for dilation in the
thoracic aorta beyond the sinus when measured by
CMR, whereas only 7/20 (35%) of the women with TS
who had dilation at more than 1 position by CMR were
identified by echocardiography. Both cases of aneurysm
found on CMR were identified by echocardiography,
and the control woman identified with dilation on CMR
was also identified to have dilation on echocardiography.
Variables predicting aortic diameter
In bivariate correlation analyses aortic diameter corre-
lated to age at all positions in TS (R = 0.22-0.5,
p < 0.03), but not to height, weight, or BMI. Correlation
to BSA was only found at pos8 (R = 0.23; p = 0.02) but
Table 3 Aortic dimensions in TS with bicuspid (TSbicuspid) and tricuspid(TStricuspid) aortic valves.
CMR TSbicuspid CMR TStricuspid TStricuspid vs TSbicuspid
n Mean ± SD (range)(mm) n Mean ± SD (range)(mm) P
Sinotubular junction 23 29.1 ± 5.4 (20-39) 66 24.4 ± 3.8 (17-36) < 0.001
Ascending aorta 23 32.4 ± 6.7 (21-48) 66 26.0 ± 4.4 (16-38) < 0.001
Aorta proximal to innominate artery 23 27.6 ± 4.6 (21-38) 66 24.7 ± 3.6 (18-34) 0.002
Prox. transverse aortic arch 19 25.8 ± 4.8 (18-34) 50 22.8 ± 3.0 (17-30) 0.002
Distal transverse aortic arch 23 20.6 ± 3.5 (14-29) 65 20.4 ± 2.3 (15-27) 0.8
Aortic isthmus 23 19.7 ± 3.2 (15-28) 65 19.1 ± 2.1 (14-24) 0.3
Descending aorta 23 21.4 ± 3.5 (17-31) 66 18.8 ± 2.4 (14-24) < 0.001
Descending aorta (diaphragm level) 23 19.7 ± 2.8 (16-27) 65 17.7 ± 2.1 (13-23) 0.001
Figure 2 Correlations between ascending (pos2) (A, left panel) and descending (pos7) (B, right panel) aortic diameter and age and
BSA. Correlations are shown separately for TS with bicuspid (TSbicuspid) and tricuspid (TStricuspid) aortic valves.
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BSA was found at pos7 (R = 0.21; p = 0.04) and pos8
(R = 0.23; p = 0.02). Karyotype correlated to aortic
dimensions at pos1 (R = 0.28, p = 0.007): women with
45,X had a larger diameter at this position when com-
pared with non-45,X (p = 0.007). An association to both
systolic 24-h AMBP (pos3: R = 0.32, p = 0.002; pos5:
R = 0.39, p < 0.001; pos6: R = 0.32, p < 0.001; pos8:
R = 0.27, p = 0.01) and diastolic 24-h AMBP (pos3:
R = 0.29, p = 0.006; pos5: R = 0.26, p = 0.015) was
present at some positions. Pulse pressure did not
correlate with aortic diameter. Earlier growth hormone,
duration of estrogen deficit as well as current antihyper-
tensive treatment correlated significantly to the diameter
at several positions, albeit not when adjusting for age
(data not shown).
Descending aortic diameters were increased in those
with a coarctation repair when compared to those with-
out such history (pos5 (p = 0.004); pos7 (p = 0.004)).
No difference was seen in aortic diameters, when
Figure 3 Individual ascending aortic diameters (pos2) in TS by CMR. The individuals are marked according to their aortic valve status.
Table 4 TS with dilatation or aneurysm at the measuring positions.
Dilatation Aneurysm c
2-test dilatation (BAV vs TAV)
ECHOCARDIOGRAPHY (n = 97)
Aortic valve sinus 8 (6) 0 0.001
CMR (n = 94)
Aortic valve sinus 11 (7) 2 (2) 0.003
Ascending aorta 12 (10) 0 < 0.001
Aorta proximal to innominate artery 11 (8) 0 < 0.002
Proximal transverse aortic arch 6 (5) 0 0.002
Distal transverse aortic arch 1 (1) 0 0.1
Aortic isthmus 1 (1) 0 0.1
Descending aorta 4 (0) 1 (1) 0.001
Descending aorta (diaphragm level) 3 (3) 0 0.004
Not all participants have obtained measurements at all positions. The first number depicts the total number with dilatation/aneurysm, while bracketed number
represents those with dilatation or aneurysm and bicuspid aortic valve. The number of individuals with dilatation at only one position was 22 (23%) anda t2
positions or more was 13 (14%).
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to TS without such phenotypic traits.
Multiple regression models
We constructed multiple linear regression models to
incorporate age, BSA, systolic AMBP, diastolic AMBP,
aortic valve morphology, and karyotype as independent
variables and aortic diameter (CMR) as the dependent
v a r i a b l e .A g e ,B S A ,b l o o dp r essure, and aortic valve
morphology emerged as independent explanatory vari-
ables at several positions. Karyotype was only an expla-
natory variable to pos1 (Table 5). The influence of these
variables varied considerably with the position of mea-
surement through the thoracic aorta. At position 6-7,
the incorporated variables contributed with more than
50% of the variation in aortic diameter, while the expla-
natory variables contributed with 30-40% to the varia-
tion in CMR diameter at pos2-5. At pos1 only 11% of
the variation in aortic diameter could be contributed
to the explanatory variables identified in this study
(Table 5).
Discussion
The present study provides several cornerstone findings
in TS: i) aortic valve configuration is a key determinant
to aortic morphology, and BAV associates with the lar-
ger aortic diameter even beyond the ascending aorta; ii)
aortic dilation can be present despite an average dia-
meter comparable to that of healthy female controls; iii)
aortic dilation is present in a substantial fraction of
non-selected adult women with TS.
Recent observations unanimously confirm that women
with TS are at increased risk of aortic dissection [1]; if
this is universal to TS, or particularly relevant only to
certain subgroups is not entirely resolved [1,16]. As in
other populations facing an increased risk of aortic dis-
section [17,18], the presence of BAV may be a key risk
factor in TS [1,16]. In daily clinical practice, prediction
of the risk of dissection is based on the finding of a
severely enlarged aorta or serial studies of aortic dimen-
sions, where larger aortic caliber or high aortic growth
rates predict increased risk. Here, the association is con-
firmed between BAV and a larger ascending aorta,
which again would confer with an increased risk of dis-
section. Interestingly, in this population where up to a
third of thoracic aortic dissections occur in the descend-
ing aorta [16], this association is extended into the
transverse aortic arch and the descending aorta, and a
further link is indicated between BAV and aortic coarc-
tation in TS. It does, however, remain to be resolved if
aortic dilation as encountered in TS can be attributed
primarily to the aortopathy complex seen in other, non-
syndromic BAV patients or if it is more directly related
to the syndrome and the combined burden of potential
cardiovascular risk factors such as hypertension, tachy-
cardia, estrogen deficiency, growth-hormone deficiency,
and impaired glucose tolerance [19,20].
Other studies have indicatedt h a tt h ep r o c e s sl e a d i n g
to aortic wall disease and dissection in TS is multifac-
torial, as BAV was present in 27% of dissections in TS
[16], which does not differ from the 31% with BAV seen
in a mixed group of 111 non-TS patients undergoing
operation for ascending aortic aneurysm [21]. The sig-
nificance of the combined impact of the syndrome
related traits, beyond BAV and aortic coarctation, is
further supported by the fact that previous studies have
shown the 45,X karyotype to confer an increased risk of
dissection [10,16,22], and with 45,X the risk of an
adverse metabolic and cardiovascular phenotype is
Table 5 Multiple linear regression model including the
independent variables: age, BSA, AMBP systolic
(AMBPsys), AMBP diastolic (AMBPdia), bi- or tricuspid
aortic valve (bi/tri), HRT deficiency, and karyotype.
Position CMR Model Significant variables
rp p
Aortic valve sinus (pos1) 0.33 0.026 BAV/TAV 0.026
Ascending aorta (pos2) 0.56 < 0.001 Age 0.006
BAV/TAV 0.001
AMBPdia 0.036
BSA 0.019
Aorta proximal to innominate
artery (pos3)
0.57 < 0.001 Age 0.001
BAV/TAV 0.045
AMBPdia 0.012
BSA 0.002
Proximal transverse aortic
arch (pos4)
0.66 < 0.001 Age < 0.001
BAV/TAV 0.004
AMBPdia 0.053
BSA 0.015
Distal transverse aortic arch
(pos5)
0.64 < 0.001 Age < 0.001
AMBPdia 0.034
BSA < 0.001
Aortic isthmus (pos6) 0.75 < 0.001 Age < 0.001
BSA < 0.001
Descending aorta (pos7) 0.66 < 0.001 Age 0.001
BAV/TAV < 0.001
AMBPsys 0.032
AMBPdia 0.004
BSA 0.001
Descending aorta (pos8)
(diaphragm level)
0.75 < 0.001 Age < 0.001
BAV/TAV < 0.001
AMBPdia 0.041
AMBPsys 0.001
BSA < 0.001
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that not only the 45,X but also elevated blood pressure
(diastolic pressure especially) carries increased risk of
larger aortic diameters in adult TS, which is in line with
high blood pressure being a risk factor for ascending
aortic dilation both in the general population [23] and
in women with TS [24].
No clear evidence exists to define the precise timing
for medical or surgical intervention in this high-risk
patient group, where the normal range for aortic mea-
surements remains to be determined. Aortic dilation in
TS is intuitively considered the principal surrogate mar-
ker for the risk of dissection, but dissections occur even
with normal aortic echocardiograms within less than
15 month prior to the event [16]. This may reflect the
sensitivity of echocardiography; the value of echocardio-
graphy as a screening tool in the TS population may be
suboptimal secondary to the widespread abnormal chest
dimensions, rendering the achievement of appropriate
echocardiographic acoustic windows difficult. In this
study, echocardiography was sensitive to severe aortic
dilatation (aneurism) but less sensitive to less progressed
dilatation as well as to dilatation at more positions; this
is in line with previous findings [25]. Alternatively, this
striking lack of association between pathologic aortic
enlargement and aortic dissection may reflect the com-
plexity of defining the pathologically enlarged aorta in
TS, where follow-up studies after thorough cardiovascu-
lar work-up are limited and have failed to identify aortic
growth or certain subgroups facing increased risk of
progression in aortic caliber [26]. Interestingly, the defi-
nition of normality is a key question extending beyond
TS, as a recent study challenges the currently used clini-
cally risk stratification for aortic dissection: severe aortic
dilation (to a degree where surgical intervention would
normally be recommended, i.e. diameters > 5.5 cm) was
only present in 41% of aortic dissection patients (all
without chromosomal disease), even if a larger diameter
was present in patients with BAV or Marfan syndrome
[27].
Different strategies have been proposed to circumvent
the issue of defining pathologic aortic dimensions in TS,
whereof BSA indexing as the aortic size index is widely
used. A strong, consistent correlation between BSA and
aortic diameter did, however, not appear in the current
cohort, contradicting previous studies of TS [7,8]. This
shortage of correlation is not a lack of statistical power,
as we have previously documented such correlation in a
pediatric population using the same imaging technique
in a cohort of more than half the size [28], and other
studies showing good correlation have not been consid-
erably higher powered [14]. Hypothetically, a prominent
association between aortic diameter and BSA observed
in children, adolescents, and younger adults becomes
less prominent with age; the multiple co-morbidities of
TS potentially impact adverse l yo na o r t i cd i m e n s i o n s ,
causing BSA to lose its significance over time. Such syn-
drome-associated co-morbidities could besides age, be
elevated blood pressure, diabetes, BAV, aortic coarcta-
tion, or karyotype. Collectively, these complex interac-
tions may not only cause aortic dimensions in adult TS
to spread over a wider range (as seen in this popula-
tion), but they may also weaken the predictive capacity
of BSA to aortic dimensions in the older TS patient: the
traits of TS impacting through childhood and adulthood
on aortic size and becomes of higher importance than
BSA. Therefore, the observed dissociation of a correla-
tion between BSA and aortic diameter in this non-
selected adult TS population, recruited from a non-car-
diology ward, may reflect a state of progressed aortic
disease. The significance of using BSA indexing to
define the TS women with large aortic size (i.e. the risk
of aortic dissection) remains to be investigated in fol-
low-up studies. But our study indicates that other fac-
tors could be of equal importance in terms of defining
the abnormal aorta in the individual patient. It further
raises the question of the correction for this variable,
not uniformly correlating linearly with aortic size, may
not be entirely unproblematic, as other important fac-
tors may be overlooked.
Alternatively to indexing for BSA, adjusting for aortic
dimensions in regions normally unaffected by the
aortic disease (the distal descending aorta), to obtain an
aortic ratio has been proposed. This measure may be
more robust to changes with age and body size [24] and
therefore more appropriate in TS. In contrast to pre-
vious observations in women with TS [8], this ratio was
not increased in our cohort compared to controls. It is
our belief, that this ratio is inherently flawed in TS
because the descending aorta was found to be abnormal
i nac o n s i d e r a b l en u m b e ro fp a t i e n t s ,a n dt h e r e f o r et h e
ratio will underestimate the extent of aortic dilatation.
Furthermore, the ratio was above the limit for patholo-
gic dimensions (aortic ratio > 1.5) in 38% in the healthy
controls.
Compared with CMR, echocardiography is universally
accessible, quick, cheap, safe and never contraindicated.
But CMR not only allows imaging of the entire thoracic
aorta but also offers an exquisite image quality in almost
all subjects, as also seen in this study in which CMR
could be performed in 95/102 (93%) of the recruited
subjects. With the now documented increased preva-
lence of aortic dilatation along the entire thoracic aorta
as well as the previously documented increased preva-
lence of coarctation as well as the elongated transverse
aortic arch [3], accurate visualization of the complete
thoracic aorta is particularly relevant in clinical follow-
up in TS. To improve imaging and avoid the use of
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Page 8 of 10contrast agents, we used a specific CMR sequence,
allowing for contrast-free and free-breathing imaging of
the entire thoracic aorta with a minimal acquisition
time. Besides obtaining measurements of high inter- and
intraobserver variability, as seen in our Bland-Altman
variability analysis, this technique allowed post-proces-
sing in any 3D plane and provided optimal conditions
for measuring a true, accurate aortic caliber. It may
therefore be of value in cardiovascular follow-up in this
high risk cardiovascular population, where the pathology
appears of multifactorial nature and where knowledge of
adequate follow-up regimens for specific TS subgroups
are limited in the face of a shortage of studies of the
aortic disease and events over time and after through
cardiovascular characterization.
Conclusion
In conclusion, aortic dilation and aneurysm, predomi-
nantly affecting the ascending aorta, are widespread in
TS. The presence of BAV identifies a TS subgroup with
significantly larger aortic dimensions; blood pressure,
karyotype, and age are additional major determinants of
thoracic aortic diameter. Although echocardiography in
most cases accurately and sufficiently identifies dilation
of the proximal part of the aorta, CMR is not only a
more sensitive technique for assessing the ascending
aorta but in particular provides high-quality imaging of
the remaining part of the thoracic aorta where significant
dilatation, native narrowing or residual obstructions after
previous repair of coarctation pose an additional aortic
burden, increasing the risk of dissection. CMR is there-
fore a key tool not only in diagnosis of aortic dilatation,
or even dissection, but is also a pivotal part of follow-up
in order to sufficiently assess aortic caliber over time.
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